Edition:
United Kingdom

Insider Trading: Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

20.88USD
18 Apr 2019
Change (% chg)

$0.08 (+0.38%)
Prev Close
$20.80
Open
$20.73
Day's High
$21.00
Day's Low
$19.80
Volume
334,708
Avg. Vol
598,564
52-wk High
$54.61
52-wk Low
$11.50

All Insider Trades
Trading Date Name Title Type Shares Traded Price
20 Mar 2019

Rolfe (Lindsey)

Officer Buy 3,437 $0.00
20 Mar 2019

Ivers-Read (Gillian C)

Officer Sell 830 $26.13
20 Mar 2019

Ivers-Read (Gillian C)

Officer Buy 1,875 $0.00
20 Mar 2019

Rolfe (Lindsey)

Officer Sell 1,729 $26.13
18 Mar 2019

Blair (James C)

Director Buy 522 $0.00
18 Mar 2019

Blair (James C)

Director Buy 701 $0.00
18 Mar 2019

Blair (James C)

Director Sell 10,000 $0.00
14 Mar 2019

Blair (James C)

Director Sell 17,056 $27.79
5 Mar 2019

Muehl Daniel W

Chief Financial Officer Buy 2,250 $0.00
5 Mar 2019

Ivers-Read (Gillian C)

Officer Sell 316 $29.29
5 Mar 2019

Ivers-Read (Gillian C)

Officer Buy 2,750 $0.00
5 Mar 2019

Muehl Daniel W

Chief Financial Officer Sell 1,060 $29.29
5 Mar 2019

Gross (Paul Edward)

General Counsel Buy 469 $0.00
5 Mar 2019

Ivers-Read (Gillian C)

Officer Sell 1,295 $29.29
5 Mar 2019

Muehl Daniel W

Chief Financial Officer Buy 469 $0.00
5 Mar 2019

Rolfe (Lindsey)

Officer Sell 1,410 $29.29
5 Mar 2019

Rolfe (Lindsey)

Officer Buy 625 $0.00
5 Mar 2019

Rolfe (Lindsey)

Officer Sell 321 $29.29
5 Mar 2019

Gross (Paul Edward)

General Counsel Buy 2,250 $0.00
5 Mar 2019

Gross (Paul Edward)

General Counsel Sell 237 $29.29
5 Mar 2019

Rolfe (Lindsey)

Officer Buy 2,750 $0.00
5 Mar 2019

Muehl Daniel W

Chief Financial Officer Sell 237 $29.29
5 Mar 2019

Ivers-Read (Gillian C)

Officer Buy 625 $0.00
5 Mar 2019

Gross (Paul Edward)

General Counsel Sell 1,088 $29.29
27 Feb 2019

Muehl Daniel W

Chief Financial Officer Buy 547 $0.00

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 248
Total Shares Held: 54,833,967
3 Mo. Net Change: -2,405,690
# New Positions: 6
# Closed Positions: 4
# Increased Positions: 14
# Reduced Positions: 19
# Net Buyers: -5

Officers & Directors

Name Age Since Current Position

M. James Barrett

75 2009 Independent Chairman of the Board

Patrick Mahaffy

55 2009 President, Chief Executive Officer, Director

Daniel Muehl

55 2016 Senior Vice President of Finance, Principal Accounting Officer and Principal Financial Officer

Gillian Ivers-Read

64 2009 Executive Vice President - Technical Operations, Chief Regulatory Officer

Lindsey Rolfe

50 2015 Executive Vice President - Clinical and Pre-Clinical Development and Pharmacovigilance and Chief Medical Officer

Robert Azelby

50 2018 Director

Richard Fair

50 2018 Director

Brian Atwood

65 2009 Independent Director

James Blair

78 2009 Independent Director

Keith Flaherty

46 2013 Independent Director

Ginger Graham

63 2013 Independent Director

Paul Klingenstein

62 2009 Independent Director

Edward McKinley

66 2009 Independent Director

Thorlef Spickschen

77 2009 Independent Director

Breanna Burkart

2015 IR Contact Officer